Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Foukakis

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Oncogene|May 17, 2018
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlationsIoannis Zerdes, Alexios Matikas, Jonas Bergh, et al.
Breast Cancer Research and Treatment|April 24, 2022
Women with short survival after diagnosis of metastatic breast cancer: a population-based registry studyCaroline Boman, Luisa Edman Kessler, Jonas Bergh, et al.
European Journal of Radiology|December 26, 2024
Effect of needle size on outcomes of vacuum-assisted excision of breast lesions. A randomized controlled trialAthanasios Zouzos, Irma Fredriksson, Andreas Karakatsanis, et al.
Oncotarget|September 3, 2016
Periostin is identified as a putative metastatic marker in breast cancer-derived exosomesIoulia Vardaki, Sophia Ceder, Dorothea Rutishauser, et al.
Breast Cancer Research and Treatment|May 28, 2011
Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, SwedenTheodoros Foukakis, Tommy Fornander, Tobias Lekberg, et al.
Breast (Edinburgh, Scotland)|June 13, 2026
A nationwide population-based study on the incidence and prognosis of HER2-positive breast cancer eligible for adjuvant pertuzumab in the modern era of neoadjuvant therapyAntonis Valachis, Xingrong Liu, Balazs Acs, et al.
The Oncologist|August 9, 2019
Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer TrialSara Mijwel, Kate A Bolam, Jacob Gerrevall, et al.
The British Journal of Surgery|June 5, 2021
Axillary evaluation in ductal cancer in situ of the breast: challenging the diagnostic accuracy of clinical practice guidelinesAndreas Karakatsanis, Petros Charalampoudis, Lida Pistioli, et al.
Acta Oncologica (Stockholm, Sweden)|August 14, 2020
Efficacy and safety of cyclin dependent kinases 4/6 inhibitors in the treatment of metastatic breast cancer: a real-world experienceLuisa Edman Kessler, Oscar Wiklander, Eva Hamberg, et al.
Cancer Treatment Reviews|July 8, 2021
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysisCaroline Boman, Ioannis Zerdes, Kira Mårtensson, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Oncogene|May 17, 2018
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlationsIoannis Zerdes, Alexios Matikas, Jonas Bergh, et al.
Breast Cancer Research and Treatment|April 24, 2022
Women with short survival after diagnosis of metastatic breast cancer: a population-based registry studyCaroline Boman, Luisa Edman Kessler, Jonas Bergh, et al.
European Journal of Radiology|December 26, 2024
Effect of needle size on outcomes of vacuum-assisted excision of breast lesions. A randomized controlled trialAthanasios Zouzos, Irma Fredriksson, Andreas Karakatsanis, et al.
Oncotarget|September 3, 2016
Periostin is identified as a putative metastatic marker in breast cancer-derived exosomesIoulia Vardaki, Sophia Ceder, Dorothea Rutishauser, et al.
Breast Cancer Research and Treatment|May 28, 2011
Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, SwedenTheodoros Foukakis, Tommy Fornander, Tobias Lekberg, et al.
Breast (Edinburgh, Scotland)|June 13, 2026
A nationwide population-based study on the incidence and prognosis of HER2-positive breast cancer eligible for adjuvant pertuzumab in the modern era of neoadjuvant therapyAntonis Valachis, Xingrong Liu, Balazs Acs, et al.
The Oncologist|August 9, 2019
Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer TrialSara Mijwel, Kate A Bolam, Jacob Gerrevall, et al.
The British Journal of Surgery|June 5, 2021
Axillary evaluation in ductal cancer in situ of the breast: challenging the diagnostic accuracy of clinical practice guidelinesAndreas Karakatsanis, Petros Charalampoudis, Lida Pistioli, et al.
Acta Oncologica (Stockholm, Sweden)|August 14, 2020
Efficacy and safety of cyclin dependent kinases 4/6 inhibitors in the treatment of metastatic breast cancer: a real-world experienceLuisa Edman Kessler, Oscar Wiklander, Eva Hamberg, et al.
Cancer Treatment Reviews|July 8, 2021
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysisCaroline Boman, Ioannis Zerdes, Kira Mårtensson, et al.
Pageof 13